Form 4: Amgen Executive Murdo Gordon Reports Stock Disposal for Tax Obligations

Murdo Gordon, EVP at Amgen, disposed of 758 shares of common stock to cover tax obligations related to vested Restricted Stock Units (RSUs).

Summary

• On May 2, 2024, Murdo Gordon, an Executive Vice President at Amgen Inc., reported a transaction involving the disposal of 758 shares of Amgen's common stock.
• The transaction was executed to satisfy tax obligations related to the vesting of Restricted Stock Units (RSUs).
• The shares were disposed of at a price of $277.37 per share.
• Following the transaction, Gordon directly owns 49,810 shares of Amgen common stock, which includes vested and unvested RSUs and Dividend Equivalents (DEs).

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock transaction by an executive. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance. It only details the executive's stock transactions and vesting schedules for RSUs.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates that an executive disposed of shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine disposal of shares by an executive for tax purposes.

Key Dates